MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System.
暂无分享,去创建一个
Lidia Navarro Vilar | Salvador Alandete Germán | Rosana Medina García | Esther Blanc García | Natalia Camarasa Lillo | José Vilar Samper | L. N. Vilar | R. M. García | S. A. Germán | J. Samper | E. Garcia | N. Lillo
[1] Marcia Koomen,et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. , 2006, Academic radiology.
[2] Thomas E Yankeelov,et al. Magnetic resonance in the era of molecular imaging of cancer. , 2011, Magnetic resonance imaging.
[3] Eun-Kyung Kim,et al. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes , 2012, European Radiology.
[4] Charles M. Perou,et al. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.
[5] Eun Sook Ko,et al. Triple-negative breast cancer: correlation between imaging and pathological findings , 2010, European Radiology.
[6] Elizabeth A. Morris,et al. Advances in breast imaging: Magnetic resonance imaging , 2006, Current oncology reports.
[7] S. Jeffrey,et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. , 2008, Radiology.
[8] Dae Young Seo,et al. Magnetic resonance imaging of breast cancer and correlation with prognostic factors , 2009, Acta radiologica.
[9] R. Warren,et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[11] A. Tutt,et al. Triple negative tumours: a critical review , 2007, Histopathology.
[12] T. Uematsu,et al. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. , 2009, Radiology.
[13] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[14] I. Ellis,et al. Preoperative assessment of prognostic factors in breast cancer , 2001, Journal of clinical pathology.
[15] N. Hylton,et al. Magnetic resonance imaging of the breast prior to biopsy. , 2004, JAMA.
[16] C. Kuhl,et al. Mammographic, US, and MR imaging phenotypes of familial breast cancer. , 2008, Radiology.
[17] Ian O Ellis,et al. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] N. Tunçbilek,et al. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. , 2005, European journal of radiology.
[19] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[20] R. Ponzone,et al. Correlations between diffusion-weighted imaging and breast cancer biomarkers , 2012, European Radiology.
[21] C. V. van Deurzen,et al. Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgery. , 2013, AJR. American journal of roentgenology.
[22] Massimo Bazzocchi,et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. , 2004, AJR. American journal of roentgenology.
[23] Les Irwig,et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] S. Rodenhuis,et al. Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] P. Sismondi,et al. Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer , 2007, European Radiology.
[26] Uwe Fischer,et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer , 2004, European Radiology.